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Introduction
Pediatric chronic nonbacterial osteomyelitis (CNO) is a
sterile inflammatory bone disorder of presumed autoim-
mune or autoinflammatory etiology. Sometimes CNO
associated with other rheumatologic conditions, such
spondyloarthritis, sacroileitis, IBD, pyoderma gangreno-
sum and psoriasis as well as a part of distinct autoinflam-
matory disease (AID), such as DIRA syndrome.
Case report
14 year old girl was admitted to our department with pain,
low and moderate grade fever, delay to thrive and history
of osteomyelitis. Her family history was unremarkable.
The onset of disease was in the age of 10 months with
small bone lesion in distal epiphysis of femur and intensive
irritability. After 1 month of immobilization she had an
intensive bone overgrowth with periostal reaction and
deformity in distal epiphysis. The bone biopsy confirmed
non-specific osteomyelitis, malignancy and infection was
excluded. Antibiotic treatment was ineffective. Her disease
had wide-spread course involving the whole femur from
distal to proximal part. The main features included bone
lesions, bone overgrowth, intensive periostal reaction and
sclerosis. The disease had persistant course without remis-
sion episodes, accompanied with pain, irritability, fever
and lead to elongation of femur (+8 cm). She had failure
to thrive since the age of 6 years. Currently she looks like
as 8 year old girl in her 14 years. Intellectual development
is normal. No signs of any other diseases, particularly
recurrent infections and involvement of other bones. A
Tc99m bone scan revealed increased uptake only in the
whole femur (+400%). Laboratorial features were specific
for AID: persisted microcytic anemia (Hb-8.0 gr/dl),
ESR>110 mm\h (n.v.<15), CRP >150 mg/l (n.v.<5), sidero-
penia. Immunological assessment was detected increased
Ig A (5.2 gr\l), Ig G (26.2 gr\l) and decreased zymozan-
induced chemoluminescence (11 Units, lower limit -160).
Chronic granulomatose disease (CGD) was confirmed
without any known foci of serious infection during her
life. Also high levels of IL1b, IL-6 and TNFa were
detected. NSAIDs appeared short temporary effect.
In our clinic we started to treat her with pamidronate
1,5 mg/kg on 1 cycle, with monthly repeated courses.
After first cycle the CRP was decreased from 150 to
19 mg/l, ESR from 58 to 12 mm\h, TNFa from 169 to
19 pg\ml. Hb increased up to 10.2 gr/dl. No pain, irritabil-
ity and fever after initiating pamidronate therapy.
Discussion
We describe a case of early presented chronic nonbacterial
osteomyelytis affected of only one bone. Early onset (first
year of life), permanent progredient course, systemic
features (fever, failure to thrive), typical laboratorial
changes (microcytic anemia, very high ESR and CRP),
increased levels of IL1b, IL-6 and TNFa are characteristic
for AID. The described case can be new form of an AID
with clinical features resembling CRMO or DIRA diseases.
Biologics can be considered to be a promising way of
further treatment as it has been reported to be successful
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